Understanding lung cancer in people with past alcohol or drug use
Part of Cancer, Lungs & breathing clinical trials.
This study looks at the experiences of people with lung cancer (NSCLC) who also have a history of alcohol or drug use. It aims to help doctors better understand and support patients facing both challenges.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older
- You have been diagnosed with non-small cell lung cancer (NSCLC)
- You have received or are receiving treatment meant to cure the cancer, like surgery, radiation, or chemotherapy
- You had a problem with alcohol or drugs (other than tobacco) in the 10 years before your cancer diagnosis
- You can speak English or Spanish fluently enough to have a 30–60 minute conversation
- You are able to give your permission to be in the study
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is looking back at the medical records of people with early-stage non-small cell lung cancer who had surgery or radiation therapy between 2018 and 2019. The goal is to understand how patients were diagnosed and treated, which may help improve care for others in the future.
This study looks at how tumor and blood biomarker results can guide treatment for people with non-small cell lung cancer (NSCLC). Depending on the cancer stage, it may follow standard-of-care treatment plans around surgery or first-line immunotherapy.
This study collects real-world information about people with lung cancer who get newer kinds of cancer drugs. It aims to understand how these innovative therapies work in everyday care and help future research.
This trial collects tissue samples from your lung tumor and any tumors that have spread to other parts of your body. They will study the genetic makeup of these samples to better understand lung cancer and improve future treatments.
This study looks at why some people who have never smoked develop lung cancer. Researchers will follow participants to learn about predictors and outcomes, with the goal of improving care for non-smokers with lung cancer.
This study looks at how people with non-small cell lung cancer experience the process of planning for and enrolling in clinical trials. It may help improve the way clinical trials are explained and supported for future patients.
Hear when a new Lung Non-Small Cell Carcinoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.